#Electrophoresis Equipment Market

[waywardunknowntheorist]

Electrophoresis Equipment Market Comprehensive Analysis, Future Prospects, Regional Trends from 2024 to 2031

The “Electrophoresis Equipment Market Share, Size, and Trends | 2031” is market research by The Insight Partners. The Electrophoresis Equipment market has perceived tides of change in the recent past. This study offers precise projections after detailed scrutiny of a range of factors impacting the business.  Considering the present market scenario, this report brings forward correct predictions on revenue, market size, and CAGR of the Electrophoresis Equipment market. The novel market research which is based on a fact-based foundation is now accessible for purchase. This report can make a variance in wide decision-making and drive business forward in the right direction.

Business is no longer a game of instincts when it comes to capitalizing on new production lines. In a highly competitive Electrophoresis Equipment market, companies may face several challenges. Having trusted market research is always endorsed for both veteran and new entrants. Electrophoresis Equipment Market report presents a thorough analysis of local, regional, and global market scenarios through the following details.

Report Attributes

Details

Segmental Coverage

Product Type

Gel Electrophoresis Systems

Capillary Electrophoresis Systems

Accessories

End Use

Hospitals and Diagnostics Centres

Academic and Research Institutes

Pharmaceutical and Biotechnology Companies

Others

Geography

North America

Europe

Asia Pacific

and South and Central America

Regional and Country Coverage

North America (US, Canada, Mexico)

Europe (UK, Germany, France, Russia, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, Australia, Rest of APAC)

South / South & Central America (Brazil, Argentina, Rest of South/South & Central America)

Middle East & Africa (South Africa, Saudi Arabia, UAE, Rest of MEA)

Market Leaders and Key Company Profiles

Bio-Rad Laboratories

GE Healthcare

Danaher Corporation

Merck Millipore

QIAGEN N.V.

Thermo Fisher Scientific Inc.

Agilent Technologies

Lonza Group Ltd.

Hoefer Inc.

Lumex Instruments

Other key companies 

Competitive Landscape

Knowing the state of rivals is a strategically right move to outperform them. This report is the right place to explore key strategies, developments, and recent launches by key Electrophoresis Equipment market players. This report emphasizes an analysis of business strategies and expected growth opportunities for brands.

Key Coverings:

Current and Future Market Estimates- Electrophoresis Equipment Market Share, CAGR, and Forecast | 2031

Market Dynamics – Drivers, Challenges, Regional Trends, and Market Opportunities

Market Segmentation – Product, Application, End-use Industries, and Regional Growth Prospects.

Competition Matrix – Key Market Players and Strategies

Recent Developments and Innovation Contributing Market Growth

Need a Customized Market Research Report?

You can always share any specific requirements that you have, and our team will adjust the scope of research offerings as per your needs.

The following are some customizations our clients frequently ask for:

The Electrophoresis Equipment market report can be customized based on specific regions/countries as per the intention of the business

The report production was facilitated as per the need and following the expected time frame

Insights and chapters tailored as per your requirements.

Depending on the preferences we may also accommodate changes in the current scope.

Key Questions Addressed in the Electrophoresis Equipment Market Research Include:

What are present Electrophoresis Equipment market values, and what can be expected in the upcoming decade?

What are the key segments in the Electrophoresis Equipment market?

What is the regional distribution of the Electrophoresis Equipment market report?

What are the key players and their recent strategies?

What are the key factors driving Electrophoresis Equipment market growth?

What are regulatory concerns and requirements businesses have to compel?

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Devices, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us: www.theinsightpartners.com

[giresearch]

DNA Alkaline Transfer Buffer Market Size, Analyzing Forecasted Outlook and Growth for 2024-2030

Global Info Research’s  report offers key insights into the recent developments in the global DNA Alkaline Transfer Buffer market that would help strategic decisions. It also provides a complete analysis of the market size, share, and potential growth prospects. Additionally, an overview of recent major trends, technological advancements, and innovations within the market are also included.Our report further provides readers with comprehensive insights and actionable analysis on the market to help them make informed decisions. Furthermore, the research report includes qualitative and quantitative analysis of the market to facilitate a comprehensive market understanding.This DNA Alkaline Transfer Buffer research report will help market players to gain an edge over their competitors and expand their presence in the market.

DNA alkaline transfer buffer is a commonly used buffer in molecular biology experiments, usually used for DNA electrophoresis or transfer processes. Its function is to maintain the pH stability of the solution, so that DNA molecules are not degraded or damaged during the operation process. According to our (Global Info Research) latest study, the global DNA Alkaline Transfer Buffer market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period. This report is a detailed and comprehensive analysis for global DNA Alkaline Transfer Buffer market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

We have conducted an analysis of the following leading players/manufacturers in the DNA Alkaline Transfer Buffer industry: Thermo Fisher、Fujifilm、MedChemExpress、Hi Media Laboratories、Leagene、Beijing Baiao Leibo Technology、Saint Biotechnology、Shanghai Fusheng Industrial、Shanghai Xinyu Biotechnology、Shanghai Shifeng Biotechnology Market segment by Type： Sodium Hydroxide Concentration: 0.5 Mol/L、Sodium Hydroxide Concentration: 1 Mol/L、Other Market segment by Application：Scientific Research、Medical Care、Other Report analysis: The DNA Alkaline Transfer Buffer report encompasses a diverse array of critical facets, comprising feasibility analysis, financial standing, merger and acquisition insights, detailed company profiles, and much more. It offers a comprehensive repository of data regarding marketing channels, raw material expenses, manufacturing facilities, and an exhaustive industry chain analysis. This treasure trove of information equips stakeholders with profound insights into the feasibility and fiscal sustainability of various facets within the market. Illuminates the strategic maneuvers executed by companies, elucidates their corporate profiles, and unravels the intricate dynamics of the industry value chain. In sum, the DNA Alkaline Transfer Buffer report delivers a comprehensive and holistic understanding of the markets multifaceted dynamics, empowering stakeholders with the knowledge they need to make informed decisions and navigate the market landscape effectively. Conducts a simultaneous analysis of production capacity, market value, product categories, and diverse applications within the DNA Alkaline Transfer Buffer market. It places a spotlight on prime regions while also performing a thorough examination of potential threats and opportunities, coupled with an all-encompassing SWOT analysis. This approach empowers stakeholders with insights into production capabilities, market worth, product diversity, and the markets application prospects. Assesses strengths, weaknesses, opportunities, and threats, offering stakeholders a comprehensive understanding of the DNA Alkaline Transfer Buffer markets landscape and the essential information needed to make well-informed decisions. Market Size Estimation & Method Of Prediction

Estimation of historical data based on secondary and primary data.

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Request Customization of Report@ https://www.globalinforesearch.com/contact-us About Us: Global Info Research is a company that digs deep into Global industry information to DNA Alkaline Transfer Buffer enterprises with market strategies and in-depth market development analysis reports. We provide market information consulting services in the Global region to DNA Alkaline Transfer Buffer enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.

[unitechusa]

The Most Reliable Laboratory Supplies Company Ever!

An increase in biotechnology financing activities, together with the most recent advances in biological and chemical research, will provide enormous growth opportunities for the laboratory supply firm.  The tools, apparatuses, and equipment used in diagnostic, research, and manufacturing applications are referred to as laboratory supplies. 

The laboratory supplies company can be divided into two categories: disposables and equipment. Medical lab Equipment, instruments, utensils, and substances used in a laboratory setting to conduct experiments, tests, analyses, and scientific research.

These materials are specifically created and manufactured to fulfill the demands of scientists, researchers, and professionals working in laboratory supplies fields such as chemistry, biology, physics, and medicine, among others.

Biotechnology lab equipment research focuses on using biological approaches to solve issues and develop profitable goods, such as genetic engineering and cell culture. It includes genetic modification for improved traits, biopharmaceutical development, sustainable industrial production of biofuels and chemicals, agricultural advancements through crop enhancements, environmental solutions such as bioremediation, and the development of novel biological systems through synthetic biology. 

Biotechnology Equipment This field contributes to the advancement of scientific knowledge and innovation in industries like healthcare, agriculture, energy, and the environment, with the goal of tackling global concerns and enhancing overall quality of life.

The expanding breadth of Medical laboratory supplies in pharmaceutical and biotechnology businesses, academic institutes, and diagnostic Laboratory Medical Supplies will provide huge potential prospects for the global market.

Equipment for Chromatography  is a versatile analytical technique used in laboratories to separate, identify, and quantify individual components within complex mixtures of substances. It relies on the differential distribution of compounds between a stationary phase and a mobile phase, allowing for the separation of molecules based on their chemical properties, size, and affinity.

For Laboratory Equipment Supplies tasks requiring heating, cooling, agitation or mixing, and pumping, electrically powered equipment is regularly employed. Fluid and vacuum pumps, lasers, power supply, electrophoresis and electrochemical apparatus, x-ray equipment, stirrers, hot plates, heating mantles, microwave ovens, and ultrasonicators are examples of electrically driven Laboratory Chemical Supplies.

To obtain precise and detailed insights into the composition of substances, researchers and analysts use various chromatographic methods such as gas chromatography (GC), liquid chromatography (LC), and thin-layer chromatography (TLC), making it an essential tool for both qualitative and quantitative analysis in scientific research and quality control processes. 

Water is commonly used as a coolant in laboratory condensers and other equipment. Although tap water is frequently used for these reasons, it should be avoided. In many areas, preserving water is crucial, making tap water unsuitable. 

Furthermore, the likelihood of a flood is considerably increased. Refrigerated recirculators can be costly, but they are favored for cooling laboratory equipment in order to preserve water and reduce the impact of floods. To avoid freezing at the refrigeration coils, use a coolant mixture of water and ethylene glycol. 

[market-insider]

Forensic Genomics Market Dynamics: Forensic Solutions in the Market

The global forensic genomics market size is expected to reach USD 1.36 billion by 2030, registering a CAGR of 14.25% in the forecast period, according to a new report by Grand View Research, Inc. This is owing to a significant increase in violent crimes, globally. Murder, intentional homicide, robbery, etc. are the key factors driving the growth of the industry. The Federal Bureau of Investigation predicted that there will be 1.31 million violent crimes in 2021. Homicides accounted for approximately 40.00% since before the pandemic, according to the FBI’s estimated homicide data. Forensic DNA profiling allows the identification of individuals of those who are already known to the investigating authorities.

Forensic Genomics Market Report Highlights

The growth of the overall market is attributed to the increasing crime rates along with the introduction of advanced technology for forensic testing

Key players are focusing on several strategic alliances, which, in turn, is driving the global industry

For instance, in August 2022, Thermo Fisher Scientific entered into collaboration with National Forensic Sciences University (NFSU) to establish the center of excellence for DNA forensics in India

The facility is equipped with advanced technologies, which would help researchers make evidence-based decisions

In August 2022, Verogen, Inc. formed a partnership agreement with Gene by Gene to accelerate Forensic Investigative Genetic Genealogy (FIGG) Adoption

The partnership would provide affordable whole genome sequencing services for complex samples and standardize bioinformatic techniques for FIGG analysis

For More Details or Sample Copy please visit link @: Forensic Genomics Market Report

New genetic markers have been produced as a result of recent research and they have the potential to address some significant shortcomings in DNA profiling techniques. In addition, several developments allow new kinds of relevant information to be obtained from biological samples. These include new molecular techniques for locating individuals that investigators were previously unaware of, and novel molecular approaches to support connections between criminal acts and sample donors. Such advancements in genomics, genetics and molecular biology are expected to enhance human forensic casework in the coming years. Advancements in technology have helped scientists create DNA fingerprints with smaller samples of DNA, therefore a suspect can be identified from a small amount of blood sample.

Next-generation Sequencing (NGS) offers results quickly and at a lower cost than other conventional techniques. Accordingly, to improve DNA testing accuracy, the number of regions used in STR analysis increased from 13 to 20 in 2017. In February 2022, researchers from the University of Washington along with the U.S. Department of Homeland Security used DNA testing of ivory shipments confiscated by law enforcement to identify the global criminal groups involved in ivory smuggling out of Africa. The kits & consumables product segment captured the highest revenue share in 2021 due to the high public & private investments in the development of DNA forensics.

The consumables include centrifuge tubes, cotton swabs, and filter baskets among others. The capillary electrophoresis method segment dominated the industry in 2021. Capillary electrophoresis is a fully automated technique used for detecting and separating Short Tandem Repeat (STR) alleles in genomic laboratories. Criminal testing was the largest application segment in 2021 owing to the increasing use of molecular testing technology for criminal investigation. North America dominated the global industry in 2021 due to various technological developments in the forensic sciences and growing investigation consent for forensic processes, such as biometric analysis methods and DNA profiling.

[themarketinsights]

Separation Systems for Commercial Biotechnology Market May Set Huge Growth by 2028

Latest released the research study on Global Separation Systems for Commercial Biotechnology Market, offers a detailed overview of the factors influencing the global business scope. Separation Systems for Commercial Biotechnology Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Separation Systems for Commercial Biotechnology The study covers emerging player’s data, including: competitive landscape, sales, revenue and global market share of top manufacturers are Thermo Fisher Scientific (United States), Danaher Corporation (United States), Agilent Technologies (United States), Waters Corporation (United States), Shimadzu Corporation (Japan), Bio-Rad Laboratories (United States), Merck & Co., Inc. (United States), QIAGEN (Germany), Sartorius (Germany), PerkinElmer, Inc. (United States)

Free Sample Report + All Related Graphs & Charts @: https://www.advancemarketanalytics.com/sample-report/17512-global-separation-systems-for-commercial-biotechnology-market

Separation Systems for Commercial Biotechnology Market Definition:

Bioseparation systems are used for the purification and separation of biological products and the equipment used for the separation of biological material from complex mixture or solution includes chromatography, membrane filters, and centrifuges. HPLC is one of the most commonly used separative techniques and also one of the fastest-growing instrumentation fields in the world. HPLCS are considered standard analytical tools in the laboratory to accurately isolate and purify organic molecules, drugs, and some peptide hormones. The United States is a recognized leader in analytical instrumentation used in biological research and thus stands at the forefront of many of the technical innovations being made in the bioprocess field.

Market Trend:

Ultrafiltration and Other Filtration Systems

HPLCS to Monitor Bioprocesses and Purify Large Quantities of Proteins such as Leukocyte Interferon

Market Drivers:

The growing number of biotech firms with huge investments in research and development is the key driving factor for the growth of the market.

Stringent Government Rules & Regulations

Technological Advancement in the Biotechnology Sector

Market Opportunities:

The use of rDNA technology to produce low-volume, high value-added products as well as high-volume products has greatly increased the need to develop more economic bioprocesses.

The Global Separation Systems for Commercial Biotechnology Market segments and Market Data Break Down are illuminated below:

by Application (Vaccines, Hormones, Proteins, Enzymes, Others), End-User (Pharmaceutical, Food & Cosmetics, Agriculture, Life Sciences Research, Others), Method (Liquid Chromatography, Membrane Filtration, Electrophoresis, Niche Separation, Centrifugation, Lab-on-a-Chip, Others)

Region Included are: North America, Europe, Asia Pacific, Oceania, South America, Middle East & Africa

Country Level Break-Up: United States, Canada, Mexico, Brazil, Argentina, Colombia, Chile, South Africa, Nigeria, Tunisia, Morocco, Germany, United Kingdom (UK), the Netherlands, Spain, Italy, Belgium, Austria, Turkey, Russia, France, Poland, Israel, United Arab Emirates, Qatar, Saudi Arabia, China, Japan, Taiwan, South Korea, Singapore, India, Australia and New Zealand etc.

Enquire for customization in Report @: https://www.advancemarketanalytics.com/enquiry-before-buy/17512-global-separation-systems-for-commercial-biotechnology-market

Strategic Points Covered in Table of Content of Global Separation Systems for Commercial Biotechnology Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Separation Systems for Commercial Biotechnology market

Chapter 2: Exclusive Summary – the basic information of the Separation Systems for Commercial Biotechnology Market.

Chapter 3: Displayingthe Market Dynamics- Drivers, Trends and Challenges of the Separation Systems for Commercial Biotechnology

Chapter 4: Presenting the Separation Systems for Commercial Biotechnology Market Factor Analysis Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.

Chapter 5: Displaying market size by Type, End User and Region 2015-2020

Chapter 6: Evaluating the leading manufacturers of the Separation Systems for Commercial Biotechnology market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile

Chapter 7: To evaluate the market by segments, by countries and by manufacturers with revenue share and sales by key countries (2021-2026).

Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

Finally, Separation Systems for Commercial Biotechnology Market is a valuable source of guidance for individuals and companies in decision framework.

Data Sources & Methodology The primary sources involves the industry experts from the Global Separation Systems for Commercial Biotechnology Market including the management organizations, processing organizations, analytics service providers of the industry’s value chain. All primary sources were interviewed to gather and authenticate qualitative & quantitative information and determine the future prospects.

In the extensive primary research process undertaken for this study, the primary sources – Postal Surveys, telephone, Online & Face-to-Face Survey were considered to obtain and verify both qualitative and quantitative aspects of this research study. When it comes to secondary sources Company's Annual reports, press Releases, Websites, Investor Presentation, Conference Call transcripts, Webinar, Journals, Regulators, National Customs and Industry Associations were given primary weight-age.

For Early Buyers | Get Up to 20% Discount on This Premium Report: https://www.advancemarketanalytics.com/request-discount/17512-global-separation-systems-for-commercial-biotechnology-market

What benefits does AMA research study is going to provide?

Latest industry influencing trends and development scenario

Open up New Markets

To Seize powerful market opportunities

Key decision in planning and to further expand market share

Identify Key Business Segments, Market proposition & Gap Analysis

Assisting in allocating marketing investments

Definitively, this report will give you an unmistakable perspective on every single reality of the market without a need to allude to some other research report or an information source. Our report will give all of you the realities about the past, present, and eventual fate of the concerned Market.

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Southeast Asia.

Contact Us: Craig Francis (PR & Marketing Manager) AMA Research & Media LLP Unit No. 429, Parsonage Road Edison, NJ New Jersey USA – 08837

[report-1]

 Glycobiology Instruments Market Size, Type, segmentation, growth and forecast 2023-2030

 Glycobiology Instruments Market

The Glycobiology Instruments Market is expected to grow from USD 1.80 Billion in 2022 to USD 3.60 Billion by 2030, at a CAGR of 9.10% during the forecast period.

Get the Sample Report: https://www.reportprime.com/enquiry/sample-report/11009

 Glycobiology Instruments Market Size

Glycobiology instruments refer to the equipment used to study glycans, which are complex macromolecules found on the surface of cells and proteins. The global glycobiology instruments market is segmented by type, application, and region. The types of instruments include mass spectrometry instruments, chromatography instruments, arrays, and others. Applications for these instruments include academic research institutes, pharmaceutical and biotechnology companies, and clinical laboratories. The market players in this industry include Merck KGaA, Agilent Technologies, Thermo Fisher Scientific, New England Biolabs, Shimadzu Corporation, Asparia Glycomics, and S-BIO. Regulatory and legal factors specific to this market include the need for validation and standardization in glycobiology analysis, as well as the importance of adhering to ethical and safe research practices. The glycobiology instruments market is expected to grow in the coming years, driven by advances in scientific research and the increasing demand for personalized medicine.

 Glycobiology Instruments Market Key Player

Merck KGaA

Agilent Technologies

Thermo Fisher Scientific

New England Biolabs

Shimadzu Corporation

Buy Now & Get Exclusive Discount on this: https://www.reportprime.com/enquiry/request-discount/11009

 Glycobiology Instruments Market Segment Analysis

The Glycobiology Instruments market is a niche industry that caters to the research and development of carbohydrates and their interactions with various biological systems. The target market for Glycobiology Instruments includes research organizations, pharmaceutical and biotechnology companies, academic institutions, and government agencies. The demand for Glycobiology Instruments is driven by the increasing need for understanding the role of carbohydrates in biological systems, drug discovery, and the development of new diagnostic tools.

One of the major factors driving revenue growth in the Glycobiology Instruments market are technological advancements in the field of Glycobiology research. The development of advanced technologies for carbohydrate analysis, such as lectin arrays, glycan microarrays, and mass spectrometry, has paved the way for more accurate and efficient analysis of carbohydrates. This has greatly boosted the demand for Glycobiology Instruments in the market.

Another factor driving revenue growth in this industry is the increasing demand for personalized medicine. Glycobiology research has already found applications in the development of personalized medicine, where carbohydrates are used as biomarkers for disease diagnosis and treatment. This trend is expected to continue and drive demand for Glycobiology Instruments.

The latest trends in the Glycobiology Instruments market include the development of high-throughput Glycobiology platforms that can analyze a vast number of carbohydrate samples simultaneously. The emergence of new analytical platforms, such as mass spectrometry and capillary electrophoresis, is also driving the Glycobiology Instruments market forward.

However, the Glycobiology Instruments market also faces several challenges. One of the major challenges is the high cost of Glycobiology Instruments, which limits its usage to well-funded research institutions and pharmaceutical companies. Another challenge is the lack of standardization in Glycobiology research, which can lead to inconsistencies in research results. The lack of skilled professionals in the field of Glycobiology is also a major challenge for the industry.

The main findings of the report indicate that the Glycobiology Instruments market is expected to grow at a steady pace in the coming years, driven by the increasing demand for personalized medicine and technological advancements in the field of carbohydrate analysis. The report recommends that manufacturers focus on developing cost-effective Glycobiology Instruments to expand the market reach and increase adoption across all research organizations. The report also recommends that manufacturers partner with academic institutions and research organizations to encourage standardization in Glycobiology research and attract skilled professionals to the field.

This report covers impact on COVID-19 and Russia-Ukraine wars in detail.

Purchase This Report: https://www.reportprime.com/checkout?id=11009&price=3590

Market Segmentation (by Application):

Academic Research Institutes

Pharmaceutical and Biotechnology Companies

Clinical Laboratories

Information is sourced from www.reportprime.com

[healthcaretechnologynews]

HPLC Market: Trends & Advancements in HbA1C & Hemoglobinopathy Testing for USA Point-of-Care

Demand for accurate and efficient testing methods for diagnosing and monitoring various medical conditions has increased in recent years. High-performance liquid chromatography (HPLC) has emerged as a robust and reliable analytical technique, playing a pivotal role in detecting and quantifying various biomarkers. In this blog, we will explore the HPLC market’s impact on HbA1C and hemoglobinopathy testing in the USA, shedding light on market trends, challenges, and advancements in point-of-care testing.

Read Full Blog Here: https://www.grgonline.com/post/hplc-market-for-hba1c-and-hemoglobinopathy-testing-trends-challenges-and-advancements-in-point-of

HPLC Market Trends

The HPLC market for HbA1C and hemoglobinopathy testing has witnessed substantial revenue growth over the past decade, largely driven by the increasing prevalence of diabetes and hemoglobin disorders in the United States. HbA1C testing, in particular, has become an indispensable tool for diabetes management. As diabetes remains a pressing public health concern, the demand for accurate and timely HbA1C testing at point-of-care facilities has surged.

Advancements in HPLC technology have facilitated the development of more sophisticated and user-friendly instruments. This has increased the efficiency and precision of HbA1C and hemoglobinopathy testing and reduced the turnaround time for results. Additionally, miniaturization and automation of HPLC systems have made point-of-care testing more accessible, enabling healthcare professionals to conduct tests on-site and promptly initiate appropriate patient management.

HPLC Market Challenges

Despite the numerous advantages of HPLC in HbA1C and hemoglobinopathy testing, the market faces several challenges that need to be addressed:

1. Cost: HPLC instruments, especially those with advanced features, can be expensive to acquire and maintain. This cost may hinder the widespread adoption of point-of-care testing facilities in resource-constrained settings.

2. Skill Requirements: Operating and maintaining HPLC equipment demands technical expertise, which may not be readily available in all healthcare settings. Adequate training and support are essential to ensure accurate and reliable test results.

3. Turnaround Time: While advancements in HPLC have improved testing efficiency, the turnaround time for results can still be a concern. Reducing this time further would allow for quicker patient diagnosis and treatment decisions.

4. Market Competition: The market for HbA1C and hemoglobinopathy testing is highly competitive, with multiple diagnostic methods available. HPLC faces competition from other point-of-care devices, such as immunoassays and capillary electrophoresis, which may impact its market revenue share.

Advancements in Point-of-care Testing

To overcome some of the challenges and enhance the HPLC market for HbA1C and hemoglobinopathy testing, significant advancements have been made in point-of-care testing in the USA:

1. Portable HPLC Systems: Technological advancements have led to the development of portable and hand-held HPLC systems. These compact devices offer greater flexibility and accessibility for point-of-care testing, enabling healthcare providers to reach patients in remote areas.

2. Integration with Electronic Health Records (EHR): Integrating HPLC devices with electronic health records streamlines data management and improves patient care coordination. This integration allows for seamless transfer of test results and facilitates a more comprehensive approach to patient management.

3. Lab-on-a-chip Technology: Lab-on-a-chip devices have shown great promise in point-of-care testing. These microfluidic systems integrate sample processing, analysis, and detection on a single chip, reducing sample volume requirements and analysis time.

4. Cost-Effective Solutions: Some companies are working on developing cost-effective HPLC systems without compromising accuracy. These budget-friendly options aim to make point-of-care testing economically viable for a broader range of healthcare facilities.

Conclusion

The HPLC market for HbA1C and hemoglobinopathy testing in the USA continues to evolve, driven by the increasing prevalence of diabetes and hemoglobin disorders. Market trends indicate a growing demand for efficient and accurate point-of-care testing solutions. Despite challenges, advancements in HPLC technology have paved the way for more accessible and user-friendly devices, offering significant benefits to healthcare professionals and patients.

As the HPLC market for point-of-care testing advances, addressing challenges related to cost, skill requirements, and turnaround time remains crucial. Continuous research and innovation are essential to drive further improvements in HPLC technology, ultimately enhancing patient care and disease management across the United States.

Visit our website now: https://www.grgonline.com/

[healthcaretoday1]

HPLC Market: Trends & Advancements in HbA1C & Hemoglobinopathy Testing for USA Point-of-Care

Demand for accurate and efficient testing methods for diagnosing and monitoring various medical conditions has increased in recent years. High-performance liquid chromatography (HPLC) has emerged as a robust and reliable analytical technique, playing a pivotal role in detecting and quantifying various biomarkers. In this blog, we will explore the HPLC market’s impact on HbA1C and hemoglobinopathy testing in the USA, shedding light on market trends, challenges, and advancements in point-of-care testing.

Read more: https://www.grgonline.com/post/hplc-market-for-hba1c-and-hemoglobinopathy-testing-trends-challenges-and-advancements-in-point-of

HPLC Market Trends

The HPLC market for HbA1C and hemoglobinopathy testing has witnessed substantial revenue growth over the past decade, largely driven by the increasing prevalence of diabetes and hemoglobin disorders in the United States. HbA1C testing, in particular, has become an indispensable tool for diabetes management. As diabetes remains a pressing public health concern, the demand for accurate and timely HbA1C testing at point-of-care facilities has surged.

Advancements in HPLC technology have facilitated the development of more sophisticated and user-friendly instruments. This has increased the efficiency and precision of HbA1C and hemoglobinopathy testing and reduced the turnaround time for results. Additionally, miniaturization and automation of HPLC systems have made point-of-care testing more accessible, enabling healthcare professionals to conduct tests on-site and promptly initiate appropriate patient management.

HPLC Market Challenges

Despite the numerous advantages of HPLC in HbA1C and hemoglobinopathy testing, the market faces several challenges that need to be addressed:

Cost:HPLC instruments, especially those with advanced features, can be expensive to acquire and maintain. This cost may hinder the widespread adoption of point-of-care testing facilities in resource-constrained settings. 

Skill Requirements:Operating and maintaining HPLC equipment demands technical expertise, which may not be readily available in all healthcare settings. Adequate training and support are essential to ensure accurate and reliable test results.

Turnaround Time:While advancements in HPLC have improved testing efficiency, the turnaround time for results can still be a concern. Reducing this time further would allow for quicker patient diagnosis and treatment decisions.

Market Competition:The market for HbA1C and hemoglobinopathy testing is highly competitive, with multiple diagnostic methods available. HPLC faces competition from other point-of-care devices, such as immunoassays and capillary electrophoresis, which may impact its market revenue share.

Advancements in Point-of-care Testing

To overcome some of the challenges and enhance the HPLC market for HbA1C and hemoglobinopathy testing, significant advancements have been made in point-of-care testing in the USA:

Portable HPLC Systems:Technological advancements have led to the development of portable and hand-held HPLC systems. These compact devices offer greater flexibility and accessibility for point-of-care testing, enabling healthcare providers to reach patients in remote areas.

Integration with Electronic Health Records (EHR):Integrating HPLC devices with electronic health records streamlines data management and improves patient care coordination. This integration allows for seamless transfer of test results and facilitates a more comprehensive approach to patient management.

Lab-on-a-chip Technology:Lab-on-a-chip devices have shown great promise in point-of-care testing. These microfluidic systems integrate sample processing, analysis, and detection on a single chip, reducing sample volume requirements and analysis time.

Cost-Effective Solutions:Some companies are working on developing cost-effective HPLC systems without compromising accuracy. These budget-friendly options aim to make point-of-care testing economically viable for a broader range of healthcare facilities.

Conclusion

The HPLC market for HbA1C and hemoglobinopathy testing in the USA continues to evolve, driven by the increasing prevalence of diabetes and hemoglobin disorders. Market trends indicate a growing demand for efficient and accurate point-of-care testing solutions. Despite challenges, advancements in HPLC technology have paved the way for more accessible and user-friendly devices, offering significant benefits to healthcare professionals and patients.

As the HPLC market for point-of-care testing advances, addressing challenges related to cost, skill requirements, and turnaround time remains crucial. Continuous research and innovation are essential to drive further improvements in HPLC technology, ultimately enhancing patient care and disease management across the United States.

[biolabequipment]

Biology Lab Equipment Manufacturers

Biology lab equipment is in high demand from the top biology lab equipment manufacturers as they help to conduct experiments, observations, and analyses related to biological sciences. 

Biology lab equipment is the best equipment to understand biology by providing students with hands-on experiences and enabling them to explore and investigate the living world. 

Chem Lab Nigeria is the undisputed biology lab equipment manufacturer for the following reasons: 

Quality Assurance: Chem Lab Nigeria has stringent quality control processes. Their rigorous testing procedures, compliance with the highest industry standards, and certifications ensure the equipment meets the required specifications and performance standards. 

Expertise and Experience: Being in the market for more than 30 plus years, Chem Lab Nigeria has built a strong reputation with extensive experience in producing biology lab equipment. Their long-standing presence has refined their manufacturing processes and gained valuable expertise meeting customer needs.

Product Range and Customization Options: Only those manufacturers who manufacture a vast range of equipment school labs prefer. 

Chem Lab Nigeria offers the most comprehensive selection of biology lab equipment that caters to your specific requirements. Along with the availability of the vast range, they provide customization options that allow you to tailor the equipment to meet your unique needs.

Research and Development: Undoubtedly, the best biological lab equipment manufacturers are the ones that invest in research and development for innovative products. Their specialized R&D department

ensures that the equipment features the latest advancements in technology and design, leading to more efficient and effective laboratory processes.

Customer Support and Service: Kudos to their prompt and responsive customer service channels that address all kinds of queries with excellent technical assistance and superb after-sales support. It helps ensure a smooth purchasing experience and ongoing support when needed.

Reputation and Reviews: Look for the best biology lab equipment manufacturer around you over the internet, and you shall get the name Chem Lab Nigeria. Honest and trusted reviews from the wide customer base give an insight into their reliability, product performance, and customer satisfaction levels. 

Compliance and Safety: Ensure the manufacturer adheres to safety standards and regulations. Check if their equipment complies with relevant certifications and approvals, indicating their commitment to producing safe and reliable products.

Price and Value: With the best biology lab equipment manufacturers, clients get the best costs but benefits like extended warranty, longevity, and various support services.

Here are some of the categories of biology lab equipment manufactured with the purpose: 

Observation and Specimen Handling

Specific biology lab equipment helps students observe and study microscopic organisms, cells, tissues, and other biological specimens. They learn how to handle samples safely and develop skills in making accurate observations.

It includes the following equipment: 

Microscopes

Slides and Coverslips

Pipettes

Petri Dishes

Forceps and Dissecting Tools

Specimen Containers

Dissecting Trays

Culturing Equipment

Centrifuges

Experimentation and Data Collection

Biology lab equipment, such as test tubes, beakers, pipettes, and graduated cylinders, helps students to conduct experiments, mix solutions, measure volumes, and collect data. Equipment used in this category are: 

Beakers

Test tubes

Graduated cylinders

Pipettes

Bunsen burners

Thermometers

pH meters

Spectrophotometers

Gel electrophoresis equipment

Incubators

Centrifuges

Shakers and stirrers

Water baths

Microplate readers

PCR machines

DNA sequencers

Autoclaves

Measurement and Quantification

Measurement is needed to accurately and precisely quantify biological samples. For instance, the researchers want to know about the mass of organisms, the volume of solutions, the rate of cell growth, and so much more. 

Accurate measurements are essential for obtaining reliable data and ensuring the validity of experimental results. 

Equipment supplied by the top Biology lab equipment suppliers in this category are: 

Balances and scales

Thermometers

pH meters

Spectrophotometers

Centrifuges

Pipettes

Micropipettes

Graduated cylinders

Burettes

Spectrometers

Gel electrophoresis apparatus

Microplate readers

Flow cytometers

DNA sequencers

Dissection and Anatomy Study

Dissection and anatomy equipment provide students with a hands-on opportunity to explore biological organisms' structure, organization, and relationships. 

Students learn about organisms' internal structures, organ systems, and physiological functions by dissecting the biological specimens and examining their anatomical features. This practical experience helps develop their observational and analytical skills, enhances their knowledge of organismal biology, and fosters a greater appreciation for the intricacies of living organisms.

Biology Lab Equipment Manufacturers manufacture the following equipment: 

Scalpels

Dissecting scissors

Forceps

Dissecting probes

Dissecting pins

Dissection trays

Dissection needles

Magnifying glass or dissecting microscope

Bone cutting tools

Organ models

Students need biology lab equipment for vast scientific inquiry, data collection, analysis, and critical thinking. 

They develop an understanding of scientific methods, biological concepts, and the importance of precise measurements and observations. 

Moreover, hands-on experiences in the biology lab encourage curiosity, engagement, and a deeper appreciation for the complexity and diversity of living organisms.

[furnituretipsworld]

Features of low temperature chillers

The low-temperature chiller is a refrigeration device that provides chilled water. It can provide -30~20°C chilled water or chemical solutions according to the needs of users. The low-temperature chiller is especially suitable for medicine, chemistry, plastics, food additives, electroplating, Electrophoresis and other production processes need to provide cooling water. So what are the characteristics of low temperature chillers?

Low temperature chiller features:

1. The lubricating oil of the compressor of the low-temperature chiller is supplied by the high and low pressure difference. The built-in oil of the compressor has a high oil separation efficiency, absorbs the noise of the unit, and ensures that the unit runs smoothly and is not easy to be damaged.

2. The low-temperature chiller control system adopts a microcomputer liquid crystal touch automatic control system, which is displayed in full Chinese and is easy to operate. The unit can be quickly and accurately controlled by touching the liquid crystal display, and the operating status of the unit, data query parameter settings, and alarm history can be checked. wait.

3. The automatic control system of the low-temperature chiller adopts PLC programmable controller or single-chip microcomputer control, which can realize automatic safety protection in phase loss, overvoltage, undervoltage, overcurrent, oil pressure, high voltage, low voltage, and electronic motor overload. PCL control can realize the automatic balance running time of the compressor to prolong the service life of the compressor.

4. Controlled by PLC and single-chip computer, it can be automatically adjusted to provide more series of cooling output, and realize dynamic automatic matching with cooling load. Make the low-temperature chiller run stably at the optimum efficiency all the time, so as to achieve the purpose of skill.

5. Provide modular installation, reduce the installation period, reduce the consumables of the pipeline, and shorten the on-site construction period.

6. The low-temperature chiller has fast cooling speed and strong safety, and is a model of the new generation of refrigeration equipment.

The characteristics of low-temperature chillers are here to share with you. Today, with the increasingly fierce market competition and the gradual maturity of chiller development technology, miniaturized and high-efficiency chillers have become a new trend. At the same time, in order to adapt to the rapid development of industrial production, more personalized and more practical products will continue to emerge.

[ameymeti2001]

Pharmacogenomics Market Worth $13.16 billion by 2029

Pharmacogenomics Market Worth $13.16 billion by 2029

According to this latest publication from Meticulous Research®, the global pharmacogenomics market is projected to reach $13.16 billion by 2029, at a CAGR of 8.6% during the forecast period 2022–2029. The growth of this market is driven by growing therapeutic applications of pharmacogenomics biomarkers, increasing adoption of personalized medicine, rising geriatric population and chronic disease prevalence, and growing awareness of adverse drug reactions. However, the high cost of personalized medicine and a lack of reimbursement for genetic testing & precision medicine restrain the market growth. The increasing application of pharmacogenomics in neurological disorders and cancer and the development of new, more advanced, and accurate diagnostic tools are creating growth opportunities for this market. However, the low awareness of pharmacogenomics/personalized medicine among people and the knowledge gap about genetic testing and its benefits pose a challenge to this market.

Pharmacogenomics Market: Future Outlook

The global pharmacogenomics market is segmented by technology (polymerase chain reaction, DNA sequencing, electrophoresis, microarray, mass spectrometry, and other technologies), application (oncology, cardiology, neurological diseases, infectious diseases, and other applications), end user (hospitals, diagnostic laboratories, academic and research institutions and other end users), and geography. The study also evaluates industry competitors and analyzes the market at regional and country levels.

Based on technology, in 2022, the polymerase chain reaction segment is expected to account for the largest share of the pharmacogenomics market. The large market share of this segment is attributed to the high availability and usage of PCR across all end users. PCR is a cost-effective alternative to NGS and other technologies. Moreover, PCR is a highly sensitive technology and provides results with high accuracy and low sample volume requirement. These benefits of PCR allow for its high adoption across all end users.

Based on application, in 2022, the oncology segment is expected to account for the largest share of the pharmacogenomics Market. The large market share of this segment is attributed to the need for more targeted approaches in cancer therapy, the benefits offered by pharmacogenomics in cancer treatment, and the prevalence of cancer worldwide. The high prevalence of cancer globally calls for early detection and targeted cancer therapy to reduce mortality due to cancer. According to the International Agency for Research on Cancer, the estimated global number of new cancer cases in 2020 was around 19.3 million.

Based on end user, in 2022, the hospitals segment is expected to account for the largest share of the Pharmacogenomics Market. Hospitals are the primary preference for diagnosing and treating any chronic or infectious disease. There is a rising trend among hospitals to equip themselves with molecular diagnostics tools. Moreover, the presence of certified medical practitioners in hospitals contributes to the higher adoption of pharmacogenomics testing. These factors further boost the growth of the pharmacogenomics market.

This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, and the Rest of Europe), Asia-Pacific (Japan, China, India, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa. Based on geography, in 2022, North America is expected to account for the largest share of the global pharmacogenomics market, followed by Europe and Asia-Pacific. The high prevalence of chronic diseases and high awareness regarding risks of diseases in the future, technological advancements in molecular and sequencing technologies, and highly developed healthcare infrastructure support the large market share of this region.

The key players operating in the global pharmacogenomics Market are F. Hoffmann-La Roche Ltd (Switzerland), Abbott Laboratories (U.S.), Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Illumina, Inc. (U.S.), OPKO Health, Inc. (U.S.), Dynamic DNA Laboratories (U.S.), Admera Health (U.S.), Qiagen N.V. (Netherlands), and Myriad Genetics, Inc. (U.S.).

𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗦𝗮𝗺𝗽𝗹𝗲 𝗥𝗲𝗽𝗼𝗿𝘁 @https://www.meticulousresearch.com/download-sample-report/cp_id=5366?utm_source=product&utm_medium=Social&utm_campaign=Product&utm_content=27-03-2023

Scope of the Report:

Pharmacogenomics Market, by Technology

Polymerase Chain Reaction

DNA Sequencing

Electrophoresis

Microarray

Mass Spectrometry

Other Technologies

(Note: Other Technologies include nucleic acid amplification technology, hybridization, and pyrosequencing)

Pharmacogenomics Market, by Application

Oncology

Cardiology

Neurologic Diseases

Infectious Diseases

Other Applications

(Note: Other Applications include pain management, psychiatry, forensic pathology, and basic research & drug development)

Pharmacogenomics Market, by End User

Hospitals

Diagnostic Laboratories

Academic & Research Institutions

Other End Users

(Other End Users include biopharmaceutical companies, clinical research organizations (CROS), and forensic laboratories)

Pharmacogenomics Market, by Geography

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Spain

Rest of Europe (RoE)

Asia-Pacific (APAC)

Japan

China

India

Rest of Asia-Pacific (RoAPAC)

Latin America

Brazil

Mexico

[market-insider]

Forensic Genomics Diagnostics: A Strategic Market Assessment

The global forensic genomics market size is expected to reach USD 1.36 billion by 2030, registering a CAGR of 14.25% in the forecast period, according to a new report by Grand View Research, Inc. This is owing to a significant increase in violent crimes, globally. Murder, intentional homicide, robbery, etc. are the key factors driving the growth of the industry. The Federal Bureau of Investigation predicted that there will be 1.31 million violent crimes in 2021. Homicides accounted for approximately 40.00% since before the pandemic, according to the FBI’s estimated homicide data. Forensic DNA profiling allows the identification of individuals of those who are already known to the investigating authorities.

Forensic Genomics Market Report Highlights

The growth of the overall market is attributed to the increasing crime rates along with the introduction of advanced technology for forensic testing

Key players are focusing on several strategic alliances, which, in turn, is driving the global industry

For instance, in August 2022, Thermo Fisher Scientific entered into collaboration with National Forensic Sciences University (NFSU) to establish the center of excellence for DNA forensics in India

The facility is equipped with advanced technologies, which would help researchers make evidence-based decisions

In August 2022, Verogen, Inc. formed a partnership agreement with Gene by Gene to accelerate Forensic Investigative Genetic Genealogy (FIGG) Adoption

The partnership would provide affordable whole genome sequencing services for complex samples and standardize bioinformatic techniques for FIGG analysis

Gain deeper insights on the market and receive your free copy with TOC now @: Forensic Genomics Market Report

New genetic markers have been produced as a result of recent research and they have the potential to address some significant shortcomings in DNA profiling techniques. In addition, several developments allow new kinds of relevant information to be obtained from biological samples. These include new molecular techniques for locating individuals that investigators were previously unaware of, and novel molecular approaches to support connections between criminal acts and sample donors. Such advancements in genomics, genetics and molecular biology are expected to enhance human forensic casework in the coming years. Advancements in technology have helped scientists create DNA fingerprints with smaller samples of DNA, therefore a suspect can be identified from a small amount of blood sample.

Next-generation Sequencing (NGS) offers results quickly and at a lower cost than other conventional techniques. Accordingly, to improve DNA testing accuracy, the number of regions used in STR analysis increased from 13 to 20 in 2017. In February 2022, researchers from the University of Washington along with the U.S. Department of Homeland Security used DNA testing of ivory shipments confiscated by law enforcement to identify the global criminal groups involved in ivory smuggling out of Africa. The kits & consumables product segment captured the highest revenue share in 2021 due to the high public & private investments in the development of DNA forensics.

The consumables include centrifuge tubes, cotton swabs, and filter baskets among others. The capillary electrophoresis method segment dominated the industry in 2021. Capillary electrophoresis is a fully automated technique used for detecting and separating Short Tandem Repeat (STR) alleles in genomic laboratories. Criminal testing was the largest application segment in 2021 owing to the increasing use of molecular testing technology for criminal investigation. North America dominated the global industry in 2021 due to various technological developments in the forensic sciences and growing investigation consent for forensic processes, such as biometric analysis methods and DNA profiling.

[vicky8588]

Gel Electrophoresis Equipment Market, Size, Share, Outlook and Growth Opportunities 2021-2028

Market Overview

· The Global Gel Electrophoresis Equipment Market is expected to grow at a high CAGR during the forecasting period (2021-2028).

· Gel electrophoresis is a process which is used to isolate mixtures based on their molecular size, including deoxyribonucleic acid (DNA), proteins, and ribonucleic acid (RNA).

· The gel electrophoresis equipment applies an electrical charge to molecules, through forcing them to travel toward their oppositely charged electrode. The method is found in all clinical and research laboratories using protein and DNA applications. Additionally, Gel Electrophoresis equipment comprises vertical gel equipment for protein separation and horizontal gel electrophoresis units for DNA separation.

Download free sample: https://www.datamintelligence.com/download-sample/gel-electrophoresis-equipment-market

 Market Dynamics

·The global gel electrophoresis equipment market is growing due to several factors such as growing demand for innovative therapies and drugs coupled with increasing research projects related to genes, proteins, & certain biomolecules, increasing technological advancements in the equipment, and among others.

·The rising demand for early diagnosis and remedial treatment of life-threatening diseases is resulting to increase in number of R&D programs aimed at the development of innovative genetic technologies as well as novel products. This has increased private and public investments as well as government funds and grants for specific disease-targeted genomic research. Increasing government funding towards genomics is one of the major factor leading to the growth of the gel electrophoresis market. Genomic researchers are increasingly opting for electrophoresis techniques due to their reliability. Genomics research is driven by government and nonprofit funding sources, augmented by private research and development (R&D) funding. For instance, the National Human Genome Research Institute (NHGRI) funds and collaborates with scientists in government, public and private institutions. The average spending on genomics research was estimated to be around $3 billion in 2010. The United States spends the most compared to other countries on genomics research, corresponding to 40% of the overall worldwide public funding. Citizens and taxpayers of several countries have funded much of the research, and have expectations about access to the resulting information and knowledge. While access to knowledge gained from all publicly funded research is desired, access is especially important for fields that have broad social impact and stimulate public dialogue. Innovate UK has up to £5 million to support capital investment in equipment that increases the UK’s capacity to produce and commercialise genomic analysis technologies. Genomics is one such field, where public concerns are raised for reasons such as health care and insurance implications, as well as personal and ancestral identification.

· Also, in March 2017, the American Association for the Advancement of Science, has proposed FY 2016 budget for the National Science Foundation (NSF) is USD 7.7 billion. This is an increase of USD 379 million or 5.2% from the FY 2015 budget of USD 7.3 billion. Out of the total funding, USD 748 million is allotted to biological sciences, including synthesizing life-like systems, understanding the human brain, and DNA sequencing. Thus, genomics is estimated to grow rapidly as a field, and attracts considerable interest in gel electrophoresis market.

·However, the gel electrophoresis market growth is hindered, as it a time-consuming technique and provides limited sample analysis.

Segmentation Analysis

·  On the basis of gel type, the gel electrophoresis equipment market is segmented into Polyacrylamide Gel, Agarose Gel, and others. Among these, the Polyacrylamide Gel is expected to grow ta the fastest growth rate over the forecast period. Polyacrylamide gel electrophoresis (PAGE) is a technique used to separate proteins based on their size. In polyacrylamide gel electrophoresis, an anionic detergent, sodium dodecyl sulfate (SDS) is used for binding to proteins and give a negative charge to them. After that, proteins are separated electrophoretically based on their size using a gel matrix which is made of polyacrylamide in an electric field. The polyacrylamide is produced as a result of the polymerization reaction between acrylamide and N,N'-methylene-bis-acrylamide (BIS) using a catalyst. The degree of polymerization or cross-linking can be controlled by adjusting the concentration of acrylamide and BIS. The more the cross-linking the harder the gel. Hardness of the gel, in turn, modulates the friction experienced by macromolecules when they travel through the gel during PAGE, thus affecting the resolution of separation.

· On the basis of applications of gel electrophoresis, the market is segmented into diagnostics, research, quality control & process validation, and others. Among these, the quality control & process validation is expected to grow at the highest growth rate during the forecast period, owing to rising use of electrophoresis in quality control of pharmaceutical formulations by analyzing the drug content of pharmaceutical formulations. Also, the hemoglobin analysis is also expected to grow at a significant growth rate over the forecast period. Hemoglobin electrophoresis is one of the most accurate , precise, and regularly used technique for DNA analysis worldwide. Gel electrophoresis equipment is expected to have large opportunities as a major application in the analysis of hemoglobin.

Geographical Share

·North America is dominating the global gel electrophoresis equipment market accounted for the largest market share in 2018, owing high presence of major pharmaceutical and biotechnology players in this region.

· The pharmaceutical and biotechnology & companies constantly focusing on developing new drug owing to which there is a high demand for electrophoresis equipment. Also, the increasing research projects based on proteins, associated biomolecules, and genes, increasing focus on development of structure-based drug designs, stringent regulatory requirements about pharmaceutical manufacturing necessitating quality control and process validation processes, and expanding research activities in the fields of genomics and proteomics are also contributing to the growth of the market in this region.

·United States is dominating the gel electrophoresis market in this region, owing to the rising support and funding activities by the government and non-government organizations. By supporting genomics research, various government bodies, like NHGRI (National Human Genome Research Institute), have supported the work on sequencing of the human genome, and fund research on the genome's structure, function, and role in health and disease. They also support studies on the ethical, legal, and social implications (ELSI) of genome research.

· The US National Human Genome Research Institute and the US National Academy of Medicine organized 90 leaders in genomic medicine from the United States and 25 other countries in Genomic Medicine Symposium in 2014, in order to identify opportunities for collaborations that promote the responsible practice of genomic medicine.

Competitive Landscape

· The global gel electrophoresis equipment market is competitive with major players competition with each other and with emerging players. Some of the major players in the market include, Thermo Fisher Scientific Inc., SERVA Electrophoresis GmbH, General Electric Company, Agilent Technologies, Bio-Rad Laboratories Inc., Hoefer Inc., Beckman Coulter Inc., Lonza Group Ltd., C.B.S Scientific Company Inc. and among others.

·The key players are adopting various growth strategies such as product launches and collaborations which are contributing to the growth of the gel electrophoresis equipment market globally. For instance,

·On May 29th 2019, Syngene launched a new range of robust horizontal and vertical gel electrophoresis equipment. The new units save scientists time and effort by providing an easy to use, versatile platform to run consistent quality DNA and protein gels for visualisation in Syngene’s imaging systems.

· In September 2019, Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, launched the Science of Opioid Dependence Kit, offering high school and undergraduate educators a simple hands-on DNA electrophoresis activity to teach complex genetics in the context of the opioid crisis.

· In July 2018, Luna Nanotech launched a ne product, PuroGEL™ Compact Gel Electrophoresis System. It is a compact horizontal electrophoresis system for quick and simple separation and analysis of DNA and RNA on an agarose gel. The system includes the gel migration tank and a control box with integrated power supply all in a single compact unit, leaving plenty of free space on your bench.

· In September 2016, Hamilton Nordic Ab launched a High-throughput, automated gel electrophoresis workstation for NGS library preparation and other genomics applications including Automated DNA Size Selection, DNA Analytics, and Automated Liquid Handling.

Report Scope

Understand the current     market scenario and viability of gel electrophoresis equipment market over     the forecast period.

Visualize     the composition of the gel electrophoresis equipment market segmentation     by product type, gel type, applications, and end-user highlighting the key     commercial assets and players.

Identify     commercial opportunities in gel electrophoresis equipment market by     analyzing trends and co-development deals.

View full report: https://www.datamintelligence.com/research-report/gel-electrophoresis-equipment-market

 Enquiry before buying: https://www.datamintelligence.com/enquiry/gel-electrophoresis-equipment-market

 About Us

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.

 For more information:

Sai Kiran

Sales Manager at DataM Intelligence

Email: info@datamintelligence.com

Tel: +1 877 441 4866

Website:

www.datamintelligence.com